Insider filing · BMEZ

Saba Capital Management, L.P. bought $759K of BlackRock Health Sciences Term (BMEZ)

Executed Sep 17 2024, disclosed Sep 19 2024, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Sep 19 2024), the stock returned -2.2% (delay-adjusted); from the execution session (Sep 17 2024), +0.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

SP Saba Capital Management, L.P. 10% owner profile →

Saba Capital Management, L.P. (10% owner) filed 334 Form 4 reports as a reporting entity in the trailing twelve months (142 purchases, 192 sales, 5 filed past the two-business-day deadline), most often in BlackRock ESG Capital Allocation Term Trust (ECAT). Across 140 priced purchase filings, the average 21-session return was +5.2% from execution and +5.2% from disclosure (delay-adjusted; derived). The largest single filing was $9.4M of ASA (134,093 sh across 2 lots, as filed), executed Feb 12.

BMEZ BMEZ BMEZ · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→